COMMUNIQUÉS West-GlobeNewswire

Pascal Biosciences Identifies Molecules in Cannabis That Stimulate the Immune System to Destroy Tumor Cells

21/02/2018 - 15:30

VANCOUVER, British Columbia and SEATTLE, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”) today announced the Company has discovered certain cannabinoids that enhance the [...]

Cognoa Hits Major Milestone Towards First AI-Based Autism Diagnostic

21/02/2018 - 15:04

PALO ALTO, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Cognoa, a company offering an AI-based platform for pediatric behavioral health diagnostics and digital therapeutics, announces that the U.S. Food and Drug [...]

Medtronic Introduces MiniMed(TM) Mio(TM) Advance Infusion Set for People with Diabetes

21/02/2018 - 15:00

New Infusion Set Offers Simpler, Faster, and More Convenient 1 Insulin Pump Experience DUBLIN - February 21, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, services and solutions, today [...]

Imprivata to Showcase Customer Success with E-prescribing for Opioids at HIMSS18

21/02/2018 - 15:00

LEXINGTON, Mass., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, will showcase innovative technologies, customer success stories, and best practices for enabling electronic [...]

La Jolla Pharmaceutical Company Announces the Treatment of First Patient in GIAPREZA™ (angiotensin II) Pediatric Study

21/02/2018 - 15:00

SAN DIEGO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ) today announced that the first pediatric patient has been treated in LJ501-CRH02, La Jolla’s open-label study of GIAPREZA TM ( [...]

CBS News Covers AXIM Biotech’s Patent Filing for Controlled-Release Chewing Gum to Provide Treatment for Opioid Addiction

21/02/2018 - 15:00

NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (AXIM ® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that CBS News covered the Company’s recent [...]

Tyme Technologies Appoints Tommy G. Thompson to Board of Directors

21/02/2018 - 15:00

NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ), a clinical-stage biotechnology company developing cancer therapeutics, today announced the appointment of former Wisconsin governor [...]

Abeona Therapeutics Announces Upcoming Conference Participation

21/02/2018 - 14:45

NEW YORK and CLEVELAND, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself

21/02/2018 - 14:31

FIT Biotech Oy Company release February 21, 2018 at 3.30 pm EET FIT Biotech Oy's Board of Directors has decided on the directed share issue without payment to the Company itself FIT Biotech Oy's Board of Directors has [...]

CRISPR Therapeutics to Participate in Four Upcoming Investor Conferences

21/02/2018 - 14:30

ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 21, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a genome editing company focused on creating transformative medicine for serious diseases, today announced [...]

Eyenovia Advances MicroPine for Myopia into Phase III Clinical Development and Appoints Stanford Professor Dr. Douglas Fredrick to its Scientific Advisory Board and Myopia Program Steering Committee

21/02/2018 - 14:30

NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Eyenovia Inc. (“Eyenovia”), (NASDAQ: EYEN ), a clinical stage biopharmaceutical company developing a pipeline of ophthalmology products utilizing its patented piezo-print [...]

Evoke Pharma Schedules Conference Call and Webcast for Fourth Quarter and Full-Year 2017 Financial Results

21/02/2018 - 14:30

SOLANA BEACH, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK ), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, announced today that the Company will [...]

Tower One Announces Final Approval and Implementation of Warrant Incentive Program and Warrant Listing on Canadian Securities Exchange

21/02/2018 - 14:17

VANCOUVER, British Columbia, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company ”) announces, further to its news release dated January 9, [...]

Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by Enzyvant, a Subsidiary of Roivant Sciences

21/02/2018 - 14:05

TUSTIN, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a company working to improve patient lives by providing high quality biologics manufacturing services to [...]

Allscripts to present at 2018 RBC Capital Markets Global Healthcare Conference

21/02/2018 - 14:01

CHICAGO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) today announced that certain members of its management team will present at the 2018 RBC Capital Markets Global Healthcare Conference, to be held at [...]

Premier Biomedical Inc., CEO William Hartman Returns to Uptick Newswire’s “Stock Day” with Everett Jolly

21/02/2018 - 14:00

PHOENIX, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical Inc., (OTC:BIEI) President & CEO, William A. Hartman today reviewed operational accomplishments of 2017 and expectations for 2018 in an interview on [...]

Momenta Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update

21/02/2018 - 14:00

--Ended 2017 with a healthy cash position of $380M -- --Recently announced FDA approval and launch of Glatopa ® 40 mg-- CAMBRIDGE, Mass., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA ) [...]

Dr. Eugene Sun Appointed to Novan Board of Directors

21/02/2018 - 14:00

Complements existing Board expertise as 30-year clinician, drug developer and former biopharmaceutical CEO Will provide expert perspective on the clinical application of the underlying nitric oxide science Will chair [...]

Amicus Therapeutics to Announce Full-Year 2017 Financial Results on February 28, 2018

21/02/2018 - 13:30

CRANBURY, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) today announced a conference call and live audio webcast on Wednesday, February 28, 2018 at 8:30 a.m. ET to discuss financial results [...]